103 related articles for article (PubMed ID: 16185290)
1. Colonic and small-intestinal phenotypes in gastric cancers: relationships with clinicopathological findings.
Mizoshita T; Tsukamoto T; Tanaka H; Takenaka Y; Kato S; Cao X; Joh T; Tatematsu M
Pathol Int; 2005 Oct; 55(10):611-8. PubMed ID: 16185290
[TBL] [Abstract][Full Text] [Related]
2. Expression of small intestinal and colonic phenotypes in complete intestinal metaplasia of the human stomach.
Tanaka H; Tsukamoto T; Mizoshita T; Inada K; Ogasawara N; Cao X; Kato S; Joh T; Tatematsu M
Virchows Arch; 2005 Nov; 447(5):806-15. PubMed ID: 16088401
[TBL] [Abstract][Full Text] [Related]
3. CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype.
Ha Kim G; Am Song G; Youn Park D; Han Lee S; Hyun Lee D; Oh Kim T; Jae Jo H; Heo J; Hwan Kang D; Cho M
Scand J Gastroenterol; 2006 Aug; 41(8):880-6. PubMed ID: 16803685
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.
Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M
Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397
[TBL] [Abstract][Full Text] [Related]
5. Loss of MUC2 expression correlates with progression along the adenoma-carcinoma sequence pathway as well as de novo carcinogenesis in the colon.
Mizoshita T; Tsukamoto T; Inada KI; Hirano N; Tajika M; Nakamura T; Ban H; Tatematsu M
Histol Histopathol; 2007 Mar; 22(3):251-60. PubMed ID: 17163399
[TBL] [Abstract][Full Text] [Related]
6. Down regulation of gastric and intestinal phenotypic expression in Epstein-Barr virus-associated stomach cancers.
Hirano N; Tsukamoto T; Mizoshita T; Koriyama C; Akiba S; Campos F; Carrasquilla G; Carrascal E; Cao X; Toyoda T; Ban H; Miki K; Tatematsu M
Histol Histopathol; 2007 Jun; 22(6):641-9. PubMed ID: 17357094
[TBL] [Abstract][Full Text] [Related]
7. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.
Almeida R; Silva E; Santos-Silva F; Silberg DG; Wang J; De Bolós C; David L
J Pathol; 2003 Jan; 199(1):36-40. PubMed ID: 12474224
[TBL] [Abstract][Full Text] [Related]
8. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.
Mizoshita T; Tsukamoto T; Nakanishi H; Inada K; Ogasawara N; Joh T; Itoh M; Yamamura Y; Tatematsu M
J Cancer Res Clin Oncol; 2003 Dec; 129(12):727-34. PubMed ID: 14557879
[TBL] [Abstract][Full Text] [Related]
9. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis.
Fan Z; Li J; Dong B; Huang X
Clin Cancer Res; 2005 Sep; 11(17):6162-70. PubMed ID: 16144916
[TBL] [Abstract][Full Text] [Related]
10. Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma.
Zhang MQ; Lin F; Hui P; Chen ZM; Ritter JH; Wang HL
Am J Clin Pathol; 2007 Nov; 128(5):808-16. PubMed ID: 17951204
[TBL] [Abstract][Full Text] [Related]
11. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE
World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165
[TBL] [Abstract][Full Text] [Related]
13. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma.
Satake S; Semba S; Matsuda Y; Usami Y; Chiba H; Sawada N; Kasuga M; Yokozaki H
Pathol Int; 2008 Mar; 58(3):156-63. PubMed ID: 18251778
[TBL] [Abstract][Full Text] [Related]
14. CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach.
Ko S; Chu KM; Luk JM; Wong BW; Yuen ST; Leung SY; Wong J
J Pathol; 2005 Apr; 205(5):615-22. PubMed ID: 15732140
[TBL] [Abstract][Full Text] [Related]
15. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes.
Tsukamoto T; Mizoshita T; Mihara M; Tanaka H; Takenaka Y; Yamamura Y; Nakamura S; Ushijima T; Tatematsu M
Histopathology; 2005 Jun; 46(6):649-58. PubMed ID: 15910596
[TBL] [Abstract][Full Text] [Related]
16. CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance.
Park DY; Srivastava A; Kim GH; Mino-Kenudson M; Deshpande V; Zukerberg LR; Song GA; Lauwers GY
Mod Pathol; 2010 Jan; 23(1):54-61. PubMed ID: 19820687
[TBL] [Abstract][Full Text] [Related]
17. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.
Domori K; Nishikura K; Ajioka Y; Aoyagi Y
Gastric Cancer; 2014 Apr; 17(2):263-72. PubMed ID: 23828549
[TBL] [Abstract][Full Text] [Related]
18. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.
Zhang X; Tsukamoto T; Mizoshita T; Ban H; Suzuki H; Toyoda T; Tatematsu M
Oncol Rep; 2009 Mar; 21(3):609-13. PubMed ID: 19212618
[TBL] [Abstract][Full Text] [Related]
19. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype.
Kumashiro Y; Yao T; Aishima S; Hirahashi M; Nishiyama K; Yamada T; Takayanagi R; Tsuneyoshi M
Hum Pathol; 2007 Jun; 38(6):857-63. PubMed ID: 17320150
[TBL] [Abstract][Full Text] [Related]
20. Relationship between biological behavior and phenotypic expression in undifferentiated-type gastric carcinomas.
Kabashima A; Yao T; Maehara Y; Tsuneyoshi M
Gastric Cancer; 2005; 8(4):220-7. PubMed ID: 16328596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
